patent Archives - Knowledge Ecology International

Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license

Posted on May 11, 2021 by Luis Gil Abinader

Today the government of Bolivia and Biolyse, a company based in Canada, signed an agreement to acquire COVID-19 vaccines manufactured by the company, if Canada grants them a compulsory license. Biolyse is a manufacturer of cancer drugs with the potential… Continue Reading →

Following KEI request for investigation, Cold Spring Harbor Labs says 7 patents require correction to disclose federal funding

Posted on October 20, 2017 by Kim Treanor

Summary:

After KEI filed a complaint with the NIH, Cold Spring Harbor Laboratory (CSHL) corrected a failure to disclose funding of at least 7 patented inventions, including one patent for the drug Sprinraza.
Since 2012, when federal funding was relevant to an invention, CSHL failed to make a disclosure on a filed patent more than half the time.

Continue Reading →

German Court Issues Compulsory License on HIV Drug Patent

Posted on September 8, 2016 by Andrew Goldman

A German patent court has ordered a compulsory license under Section 24 of the Patent Act, allowing Merck (US) to continue to market the HIV drug raltegravir (marketed as Isentress).

Continue Reading →

KEI statement on GSK’s announcement of policies to expand access to patented medicines

Posted on March 31, 2016 by James Love

GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading →

PhRMA Special 301 submission on Thailand

Posted on March 13, 2009 by James Love

The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:

Continue Reading →

Summary:

Categories